A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Бібліографічні деталі
Автор:	Islam, Nahidul
Інші автори:	Talukder, Mesbah
Формат:	Дисертація
Мова:	English
Опубліковано:	Brac University 2023
Предмети:	Psoriasis Biologics FAERS Interleukin inhibitors Alopecia Pharmacovigilance
Онлайн доступ:	http://hdl.handle.net/10361/22025

Схожі ресурси

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
за авторством: Afroza, Halima
Опубліковано: (2024)

Biologics and Biosimilars as Treatment Options for Psoriasis
за авторством: Moya, Amena Khatun
Опубліковано: (2023)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
за авторством: Bishakha, Adwiza Chakraborty
Опубліковано: (2024)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
за авторством: Islam, S.M. Zahidul
Опубліковано: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
за авторством: Khandker, Tahia Anjum
Опубліковано: (2024)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
за авторством: Onanna, Kazi
Опубліковано: (2024)

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
за авторством: Nusrat, Tanzina
Опубліковано: (2019)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
за авторством: Rahman, Ahadina
Опубліковано: (2018)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
за авторством: Meem, Manila
Опубліковано: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
за авторством: Islam, Saidul
Опубліковано: (2022)

A survey on the knowledge and attitude on pharmacovigilance among the pharmacy students of different universities of Dhaka, Bangladesh
за авторством: Albee, Md. Hamza
Опубліковано: (2017)

Identification of FAP inhibitors using in silico simulation study
за авторством: Deeba, Maliha Tasnim
Опубліковано: (2018)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
за авторством: Karim, Azrin
Опубліковано: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
за авторством: Jahan, Safrin
Опубліковано: (2023)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
за авторством: Tabassum, Nadira
Опубліковано: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
за авторством: Akter, Anika
Опубліковано: (2022)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
за авторством: Shehab, Habibul Mohsin
Опубліковано: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
за авторством: Haque, Mushfiqul
Опубліковано: (2019)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
за авторством: Bakar, Osama Bin Abu
Опубліковано: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
за авторством: Khan, Muidul Hasan
Опубліковано: (2024)

Biomarkers in the diagnosis and treatment of Covid-19
за авторством: Kabir, Syeda Shuvessa
Опубліковано: (2023)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
за авторством: Oshin, Sadia Afrin
Опубліковано: (2021)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
за авторством: Mahin, Md. Tamjidur Rahman
Опубліковано: (2024)

Female Alopecia
за авторством: TrÃ¼eb
Опубліковано: (2013)

RIPK pathway, as a potential target, for cancer treatment - a review
за авторством: Jahan, Nusrat
Опубліковано: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
за авторством: Rattry, Faria Rahman
Опубліковано: (2024)

Recent advancement of biologics in Asthma
за авторством: Evan, Al- Shahriar
Опубліковано: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
за авторством: Sorno, Rubina Haque
Опубліковано: (2024)

Cross-sectional survey to assess the knowledge, attitude and practice regarding adverse drug reactions of students of a private university
за авторством: Islam, Tarikul
Опубліковано: (2021)

A study on drug product approval by the FDA from 1930 to 2019
за авторством: Jony, Md. Nazmul Islam
Опубліковано: (2023)

Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
за авторством: Hossain, Ragib
Опубліковано: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
за авторством: Emon, Kamrul Hasan
Опубліковано: (2022)

FDA Consumer

FDA Consumer

FDA Consumer

FDA Consumer

Detection of skin diseases using deep learning
за авторством: Shodoy, Masuk Ur Rahman
Опубліковано: (2024)

Assessment of knowledge and attitude of adverse Ddug reactions among healthcare professionals in Bangladesh
за авторством: Paul, Sanjoy Kumer
Опубліковано: (2021)

Pharmacoepidemiology and Pharmacovigilance